As Middle Eastern markets experience volatility due to geopolitical tensions and shifting investor sentiment, many Gulf equities have retreated amid fears of prolonged conflict. Despite these ...
Helios Towers is back in focus as the modelled fair value nudges from £2.28 to £2.34, a modest uplift that still matters for anyone tracking the stock’s valuation story. That new figure sits neatly ...
Oracle is undertaking company wide layoffs affecting up to 18% of its global workforce in 2026. The cuts could reach about 30,000 roles, with the goal of freeing cash for large scale AI data center ...
In March 2026, Tenable Holdings launched Tenable Hexa AI, an agentic AI engine within the Tenable One Exposure Management Platform that automates security workflows and coordinates risk-reducing ...
Drift Protocol suffered a $285 million exploit, with a significant amount of stolen funds reportedly moved in USDC. Millions in illicit USDC were transferred via Circle's Cross Chain Transfer Protocol ...
KLA Corporation (NasdaqGS:KLAC) announced a new $7b share buyback program. The company approved a 21% increase to its regular dividend. These capital return moves arrive as AI related chip demand ...
US households have 25.63% of net worth in equities, the highest ever. Falling markets now threaten spending and GDP.
Arm Holdings (NasdaqGS:ARM) is moving from a pure licensing model into in-house AI chip production. The company has launched a new AGI CPU developed with Meta for advanced AI workloads. Arm announced ...
Global brand 1win announced a new partnership with American heavyweight wrestler and Tokyo 2020 Olympic champion Gable Steveson, who joins the company as a global ambassador. The collaboration was ...
Decentralized cryptocurrency exchange Drift has confirmed suffering a cyberattack in which threat actors stole hundreds of ...
Samsung Electronics, benefiting from red-hot chip prices stoked by the AI boom, is expected to book a six-fold jump in ...
Novo Nordisk released new cross trial data indicating its oral Wegovy pill produces greater weight loss than Eli Lilly’s newly FDA approved obesity pill Foundayo. The company reports fewer adverse ...